Characterization of a Novel C-type Lectin-like Gene, LSECtin
Wanli Liu,Li Tang,Ge Zhang,Wei Huang,Yan Cui,Lihai Guo,Zikuan Gou,Xiaoxiao Chen,Daifeng Jiang,Yunping Zhu,Ge-Fei Kang,Fuchu He
DOI: https://doi.org/10.1074/jbc.m311227200
2004-01-01
Abstract:A new C-type lectin-like gene encodes 293 amino acids and maps to chromosome 19p13.3 adjacent to the previously described C-type lectin genes, CD23, dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), and DC-SIGN-related protein (DC-SIGNR). The four genes form a tight cluster in an insert size of 105 kb and have analogous genomic structures. The new C-type lectin-like molecule, designated liver and lymph node sinusoidal endothelial cell C-type lectin (LSECtin), is a type II integral membrane protein of ∼40 kDa in size with a single C-type lectin-like domain at the COOH terminus, closest in homology to DC-SIGNR, DC-SIGN, and CD23. LSECtin mRNA was only expressed in liver and lymph node among 15 human tissues tested, intriguingly neither expressed on hematopoietic cell lines nor on monocyte-derived dendritic cells (DCs). Moreover, LSECtin is expressed predominantly by sinusoidal endothelial cells of human liver and lymph node and co-expressed with DC-SIGNR. LSECtin binds to mannose, GlcNAc, and fucose in a Ca2+-dependent manner but not to galactose. Our results indicate that LSECtin is a novel member of a family of proteins comprising CD23, DC-SIGN, and DC-SIGNR and might function in vivo as a lectin receptor. A new C-type lectin-like gene encodes 293 amino acids and maps to chromosome 19p13.3 adjacent to the previously described C-type lectin genes, CD23, dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), and DC-SIGN-related protein (DC-SIGNR). The four genes form a tight cluster in an insert size of 105 kb and have analogous genomic structures. The new C-type lectin-like molecule, designated liver and lymph node sinusoidal endothelial cell C-type lectin (LSECtin), is a type II integral membrane protein of ∼40 kDa in size with a single C-type lectin-like domain at the COOH terminus, closest in homology to DC-SIGNR, DC-SIGN, and CD23. LSECtin mRNA was only expressed in liver and lymph node among 15 human tissues tested, intriguingly neither expressed on hematopoietic cell lines nor on monocyte-derived dendritic cells (DCs). Moreover, LSECtin is expressed predominantly by sinusoidal endothelial cells of human liver and lymph node and co-expressed with DC-SIGNR. LSECtin binds to mannose, GlcNAc, and fucose in a Ca2+-dependent manner but not to galactose. Our results indicate that LSECtin is a novel member of a family of proteins comprising CD23, DC-SIGN, and DC-SIGNR and might function in vivo as a lectin receptor. Protein-carbohydrate interactions serve multiple functions in the immune system. A number of animal lectins (sugar-binding proteins) mediate both pathogen recognition and cell-cell interactions using structurally related Ca2+-dependent carbohydrate-recognition domains (C-type CRDs) 1The abbreviations used are: CRD, carbohydrate recognition domain; BSA, bovine serum albumin; CTLD, C-type lectin-like domain; DC, dendritic cell(s); DC-SIGN, DC-specific ICAM-3-grabbing nonintegrin; DC-SIGNR, DC-SIGN-related protein; EST, expressed sequence tag; FCS, fetal cattle serum; FACS, fluorescence-activated cell sorting; ICAM, intercellular adhesion molecule; ORF, open reading frame; PBMC, peripheral blood monocyte cell; RACE, rapid amplification of cDNA ends; CHO, Chinese hamster ovary; aa, amino acids; Ab, antibody; mAb, monoclonal antibody; contig, group of overlapping clones; LSECtin, liver and lymph node sinusoidal endothelial cell C-type lectin; sLSECtin, soluble LSECtin. (1Weis W.I. Taylor M.E. Drickamer K. Immunol. Rev. 1998; 163: 19-34Google Scholar). There are two groups of membrane-bound C-type lectins, type I and type II C-type lectins, which are distinguished from each other by the orientation of their cell surface NH2 terminus pointing outwards or into the cytoplasm of the cell, respectively. The type II C-type lectins identified so far have a single CRD at the extracellular carboxyl terminus (2Figdor C.G. van Kooyk Y. Adema G.J. Nat. Immunol. Rev. 2002; 2: 77-84Google Scholar). The genes coding for the type II C-type lectins are mainly localized in chromosome 12p12.3-p13.2 (3Trowsdale J. Barten R. Haude A. Stewart C.A. Beck S. Wilson M.J. Immunol. Rev. 2001; 181: 20-38Google Scholar) and 19p13.3 (4Soilleux E.J. Barten R. Trowsdale J. J. Immunol. 2000; 165: 2937-2942Google Scholar). The former is the natural killer gene complex, and the latter is the cluster of genes including CD23, dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), and DC-SIGN-related protein (DC-SIGNR). In the last cluster, these three genes have analogous genomic structures and form a tight cluster in an insert size of 105 kb on human chromosome 19p13.3 (4Soilleux E.J. Barten R. Trowsdale J. J. Immunol. 2000; 165: 2937-2942Google Scholar). They display similar domain composition and organization containing a short NH2-terminal cytoplasmic tail, a transmembrane region, and an extracellular region that consists of a coiled-coil neck domain and a C-terminal CRD. The close linkage and similar genomic and protein structures suggest that these three genes may have arisen via duplication of an ancestral gene (5Soilleux E.J. Clin. Sci. 2003; 104: 437-446Google Scholar). Indeed, they share some common functions in vivo in that they serve as cell-cell adhesion molecules and play an important role in the immune system (6Bonnefoy J.Y. Lecoanet-Henchoz S. Gauchat J.F. Graber P. Aubry J.P. Jeannin P. Plater-Zyberk C. Int. Rev. Immunol. 1997; 16: 113-128Google Scholar, 7Van Kooyk Y. Geijtenbeek T.B. Immunol. Rev. 2002; 186: 47-56Google Scholar, 8Bashirova A.A. Geijtenbeek T.B. van Duijnhoven G.C.F. van Vliet S.J. Eilering J.B.G. Martin M.P. Wu L. Martin T.D. Viebig N. Knolle P.A. KewalRamani V.N. van Kooyk Y. Carrington M. J. Exp. Med. 2001; 193: 671-678Google Scholar). CD23, a low affinity receptor for IgE, was first identified as a type II C-type lectin in the latter gene cluster, which was expressed on a wide variety of human hematopoietic cell types including B and T cells, follicular dendritic cells, monocytes, platelets, Langerhans cells, esoinophils, and natural killer cells (9Conrad D.H. Annu. Rev. Immunol. 1990; 8: 623-645Google Scholar). CD23 specifically recognizes at least four different ligands, including IgE (10Yukawa K. Kikutani H. Howaki H. Yamasaki K. Yokota A. Nakamura H. Barsumian E.L. Hardy R.R. Suemura M. Kishimoto T. J. Immunol. 1987; 38: 2576-2580Google Scholar), CD21 (11Aubry J.P. Pochon S. Gauchat J.F. Nueda-Marin A. Holers V.M. Graber P. Siegfried C. Bonnefoy J.Y. J. Immunol. 1994; 152: 5806-5813Google Scholar), CD18/CD11b, and CD18/CD11c β2-integrins (12Lecoanet-Henchoz S. Gauchat J.F. Aubry J.P. Graber P. Life P. Paul-Eugene N. Ferrua B. Corbi A.L. Daugs B. Plater-Zyberk C. Bonnefoy J.Y. Immunity. 1995; 3: 119-125Google Scholar). The CD23-CD21 and CD23-β2-integrin interactions are lectin-like in that CD23 recognizes specific carbohydrate structures expressed on CD21 and CD11b/c, respectively (11Aubry J.P. Pochon S. Gauchat J.F. Nueda-Marin A. Holers V.M. Graber P. Siegfried C. Bonnefoy J.Y. J. Immunol. 1994; 152: 5806-5813Google Scholar, 12Lecoanet-Henchoz S. Gauchat J.F. Aubry J.P. Graber P. Life P. Paul-Eugene N. Ferrua B. Corbi A.L. Daugs B. Plater-Zyberk C. Bonnefoy J.Y. Immunity. 1995; 3: 119-125Google Scholar). In contrast, CD23 binds deglycosylated IgE, suggesting the non-lectin-like recognition of a protein (rather than a carbohydrate) epitope (13Delespesse G. Sarfati M. Wu C.Y. Fournier S. Letellier M. Immunol. Rev. 1992; 125: 77-97Google Scholar). CD23 plays an important role in a variety of biological activities such as cell-cell adhesions, survival of B cells in germinal centers, regulation of IgE synthesis, and antigen presentation (6Bonnefoy J.Y. Lecoanet-Henchoz S. Gauchat J.F. Graber P. Aubry J.P. Jeannin P. Plater-Zyberk C. Int. Rev. Immunol. 1997; 16: 113-128Google Scholar). DC-SIGN, originally described in 1992 as a C-type lectin being able to bind the human immunodeficiency virus surface protein, gp120 (14Curtis B.M. Scharnowske S. Watson A.J. Proc. Natl. Acad. Sci. U. S. A. 1992; 89: 8356-8360Google Scholar), is expressed on dendritic cells and some subsets of macrophages (15Geijtenbeek T.B. Torensma R. van Vliet S.J. van Duijnhoven G.C. Adema G.J. van Kooyk Y. Figdor C.G. Cell. 2000; 100: 575-585Google Scholar, 16Soilleux E.J. Morris L.S. Leslie G. Chehimi J. Luo Q. Levroney E. Trowsdale J. Montaner L.J. Doms R.W. Weissman D. Coleman N. Lee B. J. Leukocyte Biol. 2002; 71: 445-457Google Scholar). DC-SIGNR, which shows 77% identity to DC-SIGN at the nuclear acid level, is highly expressed on human liver and lymph node sinusoidal and placental endothelial cells (8Bashirova A.A. Geijtenbeek T.B. van Duijnhoven G.C.F. van Vliet S.J. Eilering J.B.G. Martin M.P. Wu L. Martin T.D. Viebig N. Knolle P.A. KewalRamani V.N. van Kooyk Y. Carrington M. J. Exp. Med. 2001; 193: 671-678Google Scholar, 17Pohlmann S. Soilleux E.J. Baribaud F. Leslie G.J. Morris L.S. Trowsdale J. Lee B. Coleman N. Doms R.W. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 2670-2675Google Scholar). Both of DC-SIGN and DC-SIGNR are typical C-type lectins in that they bind ligands bearing mannose and related sugar through their CRDs (18Mitchell D.A. Fadden A.J. Drickamer K. J. Biol. Chem. 2001; 276: 28939-28945Google Scholar). DC-SIGN regulates the migration of dendritic cells and their interaction with lymphocytes through interactions with ICAM-2 on endothelium and ICAM-3 on T cells, respectively (15Geijtenbeek T.B. Torensma R. van Vliet S.J. van Duijnhoven G.C. Adema G.J. van Kooyk Y. Figdor C.G. Cell. 2000; 100: 575-585Google Scholar, 19Geijtenbeek T.B. Krooshoop D.J. Bleijs D.A. van Vliet S.J. van Duijnhoven G.C. Grabovsky V. Alon R. Figdor C.G. van Kooyk Y. Nat. Immunol. 2000; 1: 353-357Google Scholar). DC-SIGNR also binds to ICAM-3 on T cells and is involved in liver sinusoidal endothelial cells (LSEC) interactions with passing leukocytes (8Bashirova A.A. Geijtenbeek T.B. van Duijnhoven G.C.F. van Vliet S.J. Eilering J.B.G. Martin M.P. Wu L. Martin T.D. Viebig N. Knolle P.A. KewalRamani V.N. van Kooyk Y. Carrington M. J. Exp. Med. 2001; 193: 671-678Google Scholar, 17Pohlmann S. Soilleux E.J. Baribaud F. Leslie G.J. Morris L.S. Trowsdale J. Lee B. Coleman N. Doms R.W. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 2670-2675Google Scholar). To date, there have been many studies suggesting that DC-SIGN and DC-SIGNR can also facilitate infections of viral and bacterial pathogens including human immunodeficiency virus (20Geijtenbeek T.B. Kwon D.S. Torensma R. van Vliet S.J. van Duijnhoven G.C. Middel J. Cornelissen I.L. Nottet H.S. KewalRamani V.N. Littman D.R. Figdor C.G. van Kooyk Y. Cell. 2000; 100: 587-597Google Scholar), Ebola virus (21Alvarez C.P. Lasala F. Carrillo J. Muniz O. Corbi A.L. Delgado R. J. Virol. 2002; 76: 6841-6844Google Scholar), cytomegalovirus (22Halary F. Amara A. Lortat-Jacob H. Messerle M. Delaunay T. Houles C. Fieschi F. Arenzana-Seisdedos F. Moreau J.F. Dechanet-Merville J. Immunity. 2002; 17: 653-664Google Scholar), hepatitis C virus (23Lozach P.Y. Lortat-Jacob H. De Lacroix De Lavalette A. Staropoli I. Foung S. Amara A. Houles C. Fieschi F. Schwartz O. Virelizier J.L. Arenzana-Seisdedos F. Altmeyer R. J. Biol. Chem. 2003; 278: 20358-20366Google Scholar), and Mycobacterium tuberculosis (24Tailleux L. Schwartz O. Herrmann J.L. Pivert E. Jackson M. Amara A. Legres L. Dreher D. Nicod L.P. Gluckman J.C. Lagrange P.H. Gicquel B. Neyrolles O. J. Exp. Med. 2003; 97: 121-127Google Scholar, 25Geijtenbeek T.B. Van Vliet S.J. Koppel E.A. Sanchez-Hernandez M. Vandenbroucke-Grauls C.M. Appelmelk B. Van Kooyk Y. J. Exp. Med. 2003; 197: 7-17Google Scholar), in which mannose and related sugar on envelope glycoproteins of these pathogens play a key role in their interactions. Recently, many new genes with important biological functions have been detected based on large scale sequencing of human fetal liver cDNA library in our laboratory (26Qu X.H. Zhang C.G. Zhai Y. Xing G.C. Wei H.D. Yu Y.T. Wu S.F. He F.C. Gene (Amst.). 2001; 264: 37-44Google Scholar, 27Qu X. Wei H. Zhai Y. Que H. Chen Q. Tang F. Wu Y. Xing G. Zhu Y. Liu S. Fan M. He F. J. Biol. Chem. 2002; 277: 35574-35585Google Scholar, 28Zhang C. Yu Y. Zhang S. Liu M. Xing G. Wei H. Bi J. Liu X. Zhou G. Dong C. Hu Z. Zhang Y. Luo L. Wu C. Zhao S. He F. Genomics. 2000; 63: 400-408Google Scholar). To identify potential novel adhesion molecules, more than 14,000 expressed sequence tags (ESTs) of human fetal liver cDNA libraries (29Yu Y. Zhang C. Zhou G. Wu S. Qu X. Wei H. Xing G. Dong C. Zhai Y. Wan J. Ouyang S. Li L. Zhang S. Zhou K. Zhang Y. Wu C. He F. Genome Res. 2001; 11: 1392-1403Google Scholar) have been analyzed to search homologues of CD23, DC-SIGN, and DC-SIGNR, which were selected as baits, because all of them are important adhesion molecules involved in host defense. Among these ESTs, an insert clone D1210 with moderate homology to human DC-SIGNR, DC-SIGN, and CD23 at the amino acid level was selected for further study. This novel C-type lectin-like gene, termed LSECtin, is localized between CD23 and DC-SIGN, which is followed by DC-SIGNR, on chromosome 19p13.3, and these four structurally related genes form a tight cluster. In this study, we report on the molecular cloning, mapping, expression of LSECtin, and characterization of its sugar-binding activities. Cell Lines—The promyelomonocytic cell line HL60; the chronic myelogenous leukemia K562; the monocyte cell lines U937 and THP-1; the B cell lines Raji, Daudi, and Namalwa; the T cell lines Jurkat, Hut-78, and Molt-4; the natural killer cell line, NKL; and liver cancer cell lines HepG2 and BEL-7402 were all obtained from the Cell Bank (Shanghai Institute of Cell Biology, Chinese Academy of Sciences). The CHO cell line was obtained from the ATCC. Hematopoietic cell lines were cultured in RPMI 1640 (Invitrogen) supplemented with 2 mm glutamine, 10% heat-inactivated FCS (Hyclone), and 100 units/ml penicillin/streptomycin. HepG2, BEL-7402, and CHO cells were cultured in Dulbecco's modified Eagle's medium with 2 mm glutamine, 10% heat-inactivated FCS, and 100 units/ml penicillin/streptomycin. Human umbilical vein endothelial cells were prepared as previously reported (30Whelan J. Ghersa P. Hooft van Huijsduijnen R. Gray J. Chandra G. Talabot F. DeLamarter J.F. Nucleic Acids Res. 1991; 19: 2645-2653Google Scholar). Peripheral blood mononuclear cells (PBMCs) were isolated from healthy adult volunteers by Ficoll centrifugation (Amersham Biosciences). An aliquot of these PBMCs were stimulated for 72 h with phytohemagglutinin (5 μg/ml; Sigma). Peripheral blood granulocytes were purified from erythrocytes by hypotonic lysis (155 mm NH4Cl). DC cultures were obtained from peripheral blood monocytes as described elsewhere (31Romani N. Gruner S. Braug D. Lenz A. Trockenbacher B. Konwalinka G. Fritsch P.O. Steinman R.M. Schuler G. J. Exp. Med. 1994; 180: 83-93Google Scholar). In brief, PBMCs in RPMI 1640, 10% FCS were allowed to adhere to 6-well plates (Costar). After 1 h at 37 °C, the nonadherent cells were washed off by extensive washing with phosphate-buffered saline, and the adherent monocytes were cultured in RPMI 1640, 10% FCS with 1000 units/ml GM-CSF and 1000 units/ml IL-4 (R & D Systems). On day 4, the cultures were refreshed by adding culture medium supplemented with granulocyte-macrophage colony-stimulating factor and interleukin-4 (both at 500 units/ml). At day 7, nonadherent and loosely proliferating DC aggregates were collected and tested by flow cytometry for CD1α, CD86, CD83, and HLA-DR (fluorescein isothiocyanate-conjugated mAbs; Becton Dickinson) expression. Identification and Cloning of Human LSECtin—To identify novel adhesion molecules homologous to CD23, DC-SIGN, and DC-SIGNR, a cDNA library of human fetal liver of 22 weeks in our laboratory (29Yu Y. Zhang C. Zhou G. Wu S. Qu X. Wei H. Xing G. Dong C. Zhai Y. Wan J. Ouyang S. Li L. Zhang S. Zhou K. Zhang Y. Wu C. He F. Genome Res. 2001; 11: 1392-1403Google Scholar) was searched using the tBlastn algorithm with their CRD sequences. A novel human cDNA clone (D1210) homologous to human DC-SIGNR, DC-SIGN, and CD23 was isolated and characterized. An online BLAST search was performed against the public EST and nonredundant GenBank™ data base using the D1210 sequence, and then the human clones homologous to D1210 were picked for further analysis. Based on the results of ESTs, we designed an antisense primer (GSP1, 5′-GGA ACA GCT CAG TGC GGA CGT CCT CAC-3′) and a sense primer (GSP2, 5′-CCT GCG GGA ACT GCG TGA GCG CGT GAC-3′) to perform 5′-RACE and 3′-RACE, respectively. 5′-RACE and 3′-RACE were carried out using a SMARTTM RACE cDNA amplification kit (Clontech) on adapter-ligated cDNA, synthesized from 1 μg of poly(A)+ RNA from fetal liver (Clontech). 5′-RACE and 3′-RACE reactions were performed by touchdown PCR program as described by the manufacturer. In both cases, a nested PCR was performed with an inner primer, NGSP1 (5′-GCT CTC CTG CTC CAT CAG CTT CGC-3′), for 5′-RACE and NGSP2 (5′-GTG AGG ACG TCC GCA CTG AGC TGT TCC-3′) for 3′-RACE, respectively. PCRs were carried out at 95 °C for 5 min followed by 35 cycles at 94 °C for 1 min, 58 °C for 1 min, and 72 °C for 2 min. The predominant fragments were cloned into pGEM-T vector (Promega) for sequencing. DNA sequencing was carried out on an ABI Prism 377-XL DNA sequencer (PerkinElmer Life Sciences). Chromosomal Localization and Sequence Analysis of Human LSEC-tin—The full-length cDNA sequence of LSECtin was used to search the human genome and picked up its corresponding genomic sequence. The alignment analysis between the cDNA and its genomic sequence was performed to determine the boundaries of exons and introns and the intronic lengths of the LSECtin gene. The genomic sequences of DC-SIGN, DC-SIGNR, and CD23 were also obtained using their cDNA for comparison. The sequence alignment among the type II C-type lectins homologous to LSECtin was performed using the program ClustalW. Protein subsequence motif was identified using the network service SMART (available on the World Wide Web at smart.embl-heidelberg.de). Prosite information of the protein was analyzed with the TMpred program that was used to make a prediction of membrane-spanning regions and their orientation. Northern Blot and RT-PCR Analysis—Two human multiple tissue Northern Blots containing ∼2 μg of poly(RNA)+ per lane (MTN; Clontech) were hybridized to the specific probes of LSECtin and β-actin, respectively, following the manufacturer's protocol. Briefly, members were hybridized in ExpressHyb™ hybridization solution (Clontech) containing 1 × 106 cpm/ml 32P-labeled cDNA for LSECtin or β-actin. The probe for LSECtin corresponded to the open reading frame (ORF) of LSECtin and was generated with the Klenow fragment of DNA polymerase I and [α-32P]dNTP using the Primer-a-Gene® Labeling system (Promega). After being washed, the blots were exposed to x-ray film at -70 °C with an intensifying screen. Total RNAs were extracted from human peripheral blood cells, cultured cell lines, placenta, and fetal liver using Trizol reagent (Invitrogen). First cDNA was synthesized using random hexameric primers (Promega) and Moloney murine leukemia virus reverse transcriptase (Promega), as recommended by the manufacturer. Primers flanking the ORF of LSECtin were used for PCRs (forward, 5′-GCC ATG GAC ACC ACC AGG TAC AGC-3′; reverse, 5′-GAC TCA GCA GTT GTG CCT TTT CTC-3′). The PCRs were performed under the following conditions: initial denaturation at 95 °C for 5 min and then 35 cycles at 94 °C for 45 s, annealing at 58 °C for 45 s, and extension at 72 °C for 1 min. Specific primers for glyceraldehyde-3-phosphate dehydrogenase were used as an internal control for cDNA quantity (5′-ACC ACA GTC CAT GCC ATC AC-3′ as sense primer, 5′-TCC ACC ACC CTG TTG CTG TA-3′ as antisense primer). The products were visualized on ethidium bromide gels. Preparation of Anti-LSECtin Polyclonal Antibody—cDNA coding the extracellular LSECtin (aa 55–293) was generated by PCR with the primers (forward, 5′-GGA TTC AAG GCC TCC ACG GAG CGC G-3′; reverse, 5′-GTC GAC TCA GCA GTT GTG CCT TTT CTC-3′), cloned into pGEM-T vector (Promega), and sequenced. The fragment encoding the neck and CTLD domain of LSECtin was ligated immediately downstream of the hexahistidine sequence in pET-28a vector (Novagen). This recombinant vector was introduced into BL21 (DE3) cells. His-LSECtin protein was extracted from isopropyl-1-thio-β-d-galactopyranoside-treated BL21 cells in 8 m urea, 100 mm sodium phosphate, 10 mm Tris-HCl (pH 8.0) buffer and then purified under denatured conditions using Ni2+-nitrilotriacetic acid-agarose (Qiagen). Purified His-LSECtin fusion protein was subjected to preparative SDS-PAGE separation, and then the His-LSECtin protein was excised from the gel, pulverized, and emulsified with an equal volume of Freund's complete adjuvant (Sigma) (32Sambrook J. Fritsch E.F. Maniatis T. Molecular Cloning: A Laboratory Manual.2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY1989: 852-861Google Scholar). The LSECtin antigen was injected subcutaneously into adult New Zealand White rabbits. After four rounds of booster injections with Freund's incomplete adjuvant (Sigma), serum was collected, and then contaminant rabbit Abs were immunoabsorbed from the antiserum. For these purposes, antisera were first absorbed with dried BL21 cells powder, which was prepared by precipitation of BL21 cells with cold acetone for 15 min on ice (32Sambrook J. Fritsch E.F. Maniatis T. Molecular Cloning: A Laboratory Manual.2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY1989: 852-861Google Scholar), and then with CHO cells, which had been fixed with 4% paraformaldehyde and permeabilized with 0.2% (v/v) Triton X-100. The IgG fraction of this absorbed antiserum was purified by an rProtein A FF column (Amersham Biosciences). The IgG fraction of preimmune serum was also purified and served as rabbit control IgG. Immunoblotting and Immunofluorescence Analysis—The whole coding region of LSECtin was initially obtained by RT-PCR on the fetal liver total RNA as described above. PCR products were cloned into pGEM-T vector (Promega) and sequenced. The entire coding sequence of LSECtin was subcloned in-frame into pcDNA3.1A vector (Invitrogen) to produce the construct allowing the expression of C-terminal tagged Myc-His fusion protein. CHO cells were transfected with 1 μg of plasmid using LipofectAMINE™ 2000 (Invitrogen) and selected for 10–14 days in presence of 800 μg/ml G418 (Invitrogen). Resistant populations were enriched for cells expressing LSECtin and maintained in Dulbecco's modified Eagle's medium, 10% FCS supplemented with 300 μg/ml G418. CHO cells stably expressing LSECtin (CHO-LSECtin) and CHO cells transfected with an empty vector (mock cells) were treated in a lysis buffer containing 20 m Tris-HCl, pH 8.0, 150 mm NaCl, 0.15% Triton X-100, 1 mm MgCl2, 2 mm CaCl2, and a mixture of protease inhibitors (Roche Applied Science). Samples were separated by 12% SDS-PAGE under reducing conditions or by 10% SDS-PAGE under nonreducing conditions and transferred onto polyvinylidene fluoride membranes (Millipore Corp.), which were blotted either with rabbit anti-LSECtin serum (1.5 μg/ml) or anti-Myc mAb (0.5 μg/ml). After an extensive wash, membranes were further blotted with horseradish peroxidase-conjugated goat anti-rabbit or anti-mouse IgG (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) and developed with the ECL system (Amersham Biosciences). For detecting LSECtin protein in fetal liver, the membrane proteins were extracted from fetal liver tissue using an aqueous two-phase partitioning system according to previously reported methods (33Morre D.J. Morre D.M. BioTechniques. 1989; 7: 946-958Google Scholar). The membrane and cytosolic fractions and crude lysates of fetal liver tissues were separated by 12% SDS-PAGE under reduced conditions and then immunoblotted as described above. For immunofluorescence, CHO-LSECtin cultured on glass coverslips were fixed in 4% paraformaldehyde, blocked with 5% bovine serum albumin (BSA) for 2 h at 37 °C, and stained with rabbit anti-LSECtin (5 μg/ml), anti-Myc mAb (2.5 μg/ml), or preimmune rabbit IgG (5 μg/ml) according to the standard procedure (34Harlow E. Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY1998: 72-79Google Scholar). All cell samples were viewed on an epifluorescence microscope (Olympus). For flow cytometric analysis, CHO-LSECtin and mock cells were freed from culture plates using 0.02% EDTA in phosphate-buffered saline. For staining, 2 × 105 cells were incubated in ice-cold phosphate-buffered saline containing 2% BSA, 0.02% sodium azide (FACS buffer), and rabbit anti-LSECtin (5 μg/ml) or anti-Myc mAb (2.5 μg/ml). After 30 min at 4 °C, the cells were washed with the FACS buffer and recovered in 100 μl of FACS buffer containing 2 μg of fluorescein isothiocyanate-conjugated antibody against rabbit or mouse IgG (Santa Cruz) per ml. Cells were incubated for 30 min at 4 °C, washed with FACS buffer, and analyzed by a FACSCalibur apparatus (Becton Dickinson). Immunohistochemistry—5-μm paraffin sections of normal human liver and lymph node tissues were obtained from Dr. Zhao at the Center of Cancer Medicine, Beijing. Rehydrated paraffin sections were pressure-cooked for 3 min in 10 mm sodium citrate buffer, pH 6.0. After washing, the sections were preblocked in 0.5% hydrogen peroxide for 30 min and then blocked in 10% normal goat serum for 2 h. Then the sections were incubated with rabbit anti-LSECtin serum (5 μg/ml), rabbit anti-von Willerbrand factor (1:50 dilution), and preimmunization rabbit IgG (5 μg/ml) for 60 min at 37 °C, respectively. Subsequently, sections were incubated with biotinylated goat anti-rabbit IgG (Santa Cruz Biotechnology) for 30 min and finally with streptavidin coupled to peroxidase (Santa Cruz Biotechnology) for 30 min. After washing, enzyme activity was developed using 3,3-diaminobenzidine (Santa Cruz Biotechnology), and the sections were counterstained with hematoxylin. Double immunofluorescence staining was performed on formalin-fixed liver and lymph node tissues using rabbit anti-LSECtin serum and goat anti-DC-SIGNR. Antigen unmasking was done as described above. After blocking in 1% bovine serum albumin, 10% house serum, 10% chicken serum, both primary antibodies (5 μg/ml) were added overnight at 4 °C. Sections were washed with TBS and incubated for 30 min at 37 °C either with red-conjugated chicken anti-goat antibody (Santa Cruz Biotechnology) or biotinylated horse anti-rabbit IgG antibody (Santa Cruz Biotechnology) detected with fluorescein isothiocyanate-conjugated streptavidin. The stained slides were analyzed by using a conventional fluorescence microscope (Olympus). Preparation of LSECtin-Fc Fusion Protein—Recombinant chimeras containing the entire extracellular region of LSECtin fused to the Fc region of human IgG1 (LSECtin-Fc) were generated by PCR using fetal liver cDNA. The forward and reverse primers were used (5′-GC AAG CTT AAG GCC TCC ACG GAG CGC-3′ and 5′-GGC TCT AGA GCA GTT GTG CCT TTT CTC-3′). The PCR product was cloned in-frame downstream of the signal sequence of CD33 in Signal pIgplus vector (35Freeman S.D. Kelm S. Barber E.K. Crocker P.R. Blood. 1995; 85: 2005-2012Google Scholar). Plasmids were transfected into CHO cells by LipofectAMINE™ 2000. The cells stably expressing LSECtin-Fc were selected by G418 as described above. After 5 days of incubation in a non-protein-containing CD CHO medium (Invitrogen) with 300 μg/ml G418, the culture supernatant was harvested, followed by affinity chromatography with rProtein A FF column, and then examined by immunoblotting with anti-Fc mAb (Sigma). Sugar Binding Assays—Sugar binding assays were performed as previously reported (36East L. Rushton S. Taylor M.E. Isacke C.M. J. Biol. Chem. 2002; 277: 50469-50475Google Scholar). For LSECtin-Fc chimeras, 200 μl of CHO tissue culture supernatant in 800 μl of loading buffer (150 mm NaCl, 25 mm Tris-HCl pH 8.0, 25 mm CaCl2, and 1 mm MgCl2) was loaded onto 1-ml columns of mannose-, GlcNAc-, fucose-, or galactose-agarose (Sigma). The flow-through was collected, and the columns were washed with 8 × 1 ml of loading buffer followed by 8 × 1 ml of elution buffer (150 mm NaCl, 25 mm Tris-HCl, pH 8.0, and 10 mm EDTA). For CHOLSECtin cells, cells were lysed in detergent extraction solution (150 mm NaCl, 10 mm Tris-HCl, pH 8.0, 0.15% Triton X-100, 1 mm MgCl2, and 10 mm CaCl2). Lysate was incubated on ice for 30 min before centrifugation at 4 °C and 14,000 × g, and the supernatant was collected. 400 μl of supernatant was added to 600 μl of loading buffer (150 mm NaCl, 25 mm Tris-HCl, pH 8.0, 25 mm CaCl2, 1 mm MgCl2, and 0.15% Triton X-100) and applied to the columns. The columns were washed in loading buffer and eluted in elution buffer (150 mm NaCl, 25 mm Tris-HCl, pH 8.0, 0.15% Triton X-100, and 10 mm EDTA). Fractions were precipitated by incubation with 20 μg of BSA and 0.5 ml of 30% trichloroacetic acid for 30 min on ice and then centrifuged for 30 min at 4 °C, 15,000 × g. The pellets were washed twice in 1:1 ethanol ether, air-dried, and resuspended in 40 μl of reducing sample buffer. Samples were resolved by 12% SDS-PAGE and analyzed by Western blotting with anti-LSECtin antibody. Sugar Competition Assays—First, Man30-BSA (E.-Y. Laboratories) was labeled with biotin using EZ-Link TFP-PEO-Biotin (Pierce) according to the protocol recommended by the manufacturer. Purified sLSEC-tin-Fc fusion proteins were immobilized on enzyme-linked immunosorbent assay plates (NUNC, Denmark) by overnight incubation of 200 μg/ml stock solution at 4 °C (50 μl/well). After blocking of the wells usi